Investors / Netherlands / Meneldor
Meneldor
Venture capital · Netherlands · Europe
Meneldor is a Dutch life-sciences investment firm that backs science with capital to build and scale European biopharma companies. It invests in science-driven innovations addressing unmet medical needs that can be accelerated through translational strategies.
Invests inHealthcare & Biotech
In its own wordslife sciencesbiopharmahealthcaretranslational science
Your fit with Meneldor
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsMeneldor lists 4 checked portfolio companies on its own site and is named in 1 funding round. Its most frequent entry is Series A, 100% of the companies with a known first round. Its largest theme is Healthcare & Biotech (100%). 67% of its companies are based in United Kingdom. It invests most often alongside Investinor, Lightstone Ventures and NEA.
Counts come from funding rounds that name Meneldor, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Entry stage
share of companies by the stage of its first roundMeneldor does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 100% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 0 | 0 |
| '26 | 1 | 0 |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Investinor | 1 |
| Lightstone Ventures | 1 |
| NEA | 1 |
| Northstar Ventures | 1 |
| Novartis Venture Fund | 1 |
| Praetura Ventures | 1 |
| Ysios Capital | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers4100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherCompare Meneldor head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
4 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Aptamer Group develops custom solutions using their Optimer affinity platform to solve targeting challenges in the life sciences, with next-generation aptamers. | Healthcare & Biotech | Portfolio page | ||
| Hemispherian is a clinical-stage pharmaceutical company developing a novel class of small molecule drugs to treat cancer. | Healthcare & Biotech | Portfolio page | ||
| LightOx is developing new light activated drug compounds for the treatment of early-stage mouth cancers and other conditions. | Healthcare & Biotech | Portfolio page | ||
| Tagworks Pharmaceuticals develops and tests new treatments for cancer using its Click-to-Release technology | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- meneldor.nl
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 15 Apr 2026
- Companies checked
- 4
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Meneldor's profile as data
Pull Meneldor's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/meneldor.nl
# also
GET /v1/firms/meneldor.nl/portfolio
GET /v1/firms/meneldor.nl/coinvestors
GET /v1/firms/meneldor.nl/news